Abiopharma

🔍 Dillon Mary N (Executive)

Company: American Airlines Group Inc. (AAL)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 3,031 shares of common stock (Direct)
  Date: 2026-03-24 | Code: A | equity_swap_involved: false | shares_owned_after: 3,031.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Restricted stock units will vest fully upon the earlier of June 10, 2026, or the next annual meeting of stockholders following the grant date, subject to the continued service of the reporting person through the vesting date.